Bg. Harbrecht et al., TUMOR-NECROSIS-FACTOR-ALPHA REGULATES IN-VIVO NITRIC-OXIDE SYNTHESIS AND INDUCES LIVER-INJURY DURING ENDOTOXEMIA, Hepatology, 20(4), 1994, pp. 1055-1060
Tumor necrosis factor-alpha is a principal mediator of the pathophysio
logical effects of endotoxemia and endotoxin shock. Tumor necrosis fac
tor-alpha also contributes to the stimulation of nitric oxide synthesi
s by the induction of the enzyme nitric oxide synthase in a variety of
tissues. Although the importance of tumor necrosis factor-alpha in th
e induction of nitric oxide synthase activity in vitro is well known,
its role in in vivo nitric oxide synthesis has not been convincingly e
stablished. We were interested in determining whether tumor necrosis f
actor-alpha plays a significant role in the in vivo induction of nitri
c oxide synthesis. In Corynebacterium parvum-primed mice, lipopolysacc
haride injection resulted in elevated serum tumor necrosis factor-alph
a levels early and increased hepatic enzyme release (641 +/- 80 IU AST
/L; 22.7 +/- 1.9 IU ornithine carbamoyltransferase per liter) and plas
ma nitrite and nitrate (804 +/- 84 mu mol/L) 5 hr after lipopolysaccha
ride injection. Polyclonal rabbit anti-mouse anti-tumor necrosis facto
r-alpha reduced in vivo tumor necrosis factor alpha-levels (1 hr, 7,33
2 +/- 1,492 U tumor necrosis factor-alpha per milliliter) and reduced
nitric oxide synthesis as measured by plasma nitrite and nitrate (352
+/- 69 mu mol/L). Polyclonal rabbit anti-mouse anti-tumor necrosis fac
tor-alpha also reduced lipopolysaccharide-induced hepatic enzyme relea
se (428 +/- 33 IU AST/L; 16.0 +/- 2.5 IU ornithine carbamoyltransferas
e per liter). N-G-monomethyl-L-arginine, a competitive inhibitor of ni
tric oxide synthesis, also decreased plasma nitrite and nitrate (104 /- 9 mu mol/L) but increased the lipopolysaccharide induced hepatic in
jury (797 +/- 66 IU AST/L; 33.1 +/- 2.1 IU ornithine carbamoyltransfer
ase per liter). These results show that tumor necrosis factor-alpha no
t only acts as an in vivo signal for the induction of nitric oxide syn
thesis but also acts as a mediator of the lipopolysaccharide-induced h
epatic injury. The mechanism by which tumor necrosis factor-alpha exer
ts its damaging effect on hepatic cells has not been determined but ap
pears to be independent of its induction of nitric oxide synthesis.